CPHI 2015 | BRASIL

1 CPHI 2015 | Madrid | Espanha


INDEX

Brazilian Pharma Solutions ......................................................................................................................................4

Abiquifi ................................................................................................................................................................................5

Apex-Brasil.........................................................................................................................................................................6

Partners ...............................................................................................................................................................................7

Brazilian Pharmaceutical Market ..........................................................................................................................8

Cristália Produtos Químicos Farmacêuticos ............................................................................................... 10

Eurofarma Laboratorios S.A. ................................................................................................................................ 11

Centroflora CMS .......................................................................................................................................................... 12

Biolab Farmacêutica ................................................................................................................................................. 13

EMS Pharma .................................................................................................................................................................. 14

Kin Master Produtos Químicos Ltda. ............................................................................................................... 15

Libbs .................................................................................................................................................................................. 16

Nortec Química ........................................................................................................................................................... 17

Extrasul ............................................................................................................................................................................. 18

Globe Química ............................................................................................................................................................. 19

IQT – Taubaté Chemical Industry ......................................................................................................................20

União Química Farmacêutica Nacional S/A ................................................................................................ 21

Atitude ..............................................................................................................................................................................22

Biolotus ............................................................................................................................................................................22

CAEP - Centro Avançado de Estudos e Pesquisas .................................................................................23

Biomm ..............................................................................................................................................................................23

Ecotag ...............................................................................................................................................................................24

Geolab ..............................................................................................................................................................................24

T&B Pharma ...................................................................................................................................................................25

Orygen..............................................................................................................................................................................25

Blanver ..............................................................................................................................................................................26

Formil ................................................................................................................................................................................26


Brazilian Pharma Solutions

FURTHER INFORMATION:

[email protected]

+ 55 (11) 2638-4487 / 4519

www.brazilianpharmasolutions.com.br/

The Brazilian Pharmachemical Industry Association (Abiquifi) and the

Brazilian Trade and Investment Promotion Agency (Apex-Brasil) develop,

in partnership, the project of the internationalization of pharmachemical,

pharmaceutical, animal health and biotechnology brazilian sectors. They

also have the support of other industry organizations as Sindusfarma,

Alanac, Interfarma, Pró-Genericos and Abifina.

The initiative aims to expand the participation of the Brazilian Companies

from into the international scenario, seeking to increase exports, exchange

of technology, attraction of investments and internationalization of the

sector. It promotes actions in business intelligence, international marketing,

prospective missions, building export capacity, international fairs, business

rounds and trade missions directed to different target markets, including

countries from all five continents.


[email protected]

+55 21 2220-3005

www.abiquifi.org.br

Abiquifi

The Brazilian Association of Pharmaceutical Ingredients Producers (Abiquifi)

is a nonprofit company founded in 1983 and brings together companies

from the pharmachemical and pharmaceutical inputs’ sector. Its main goal

is stimulate the development of their production in Brazil.

Abiquifi has its own website on the internet (www.abiquifi.org.br) with

various market information, statistics, relevant laws and many other important

data; it publishes an annual index which records all pharmachemicals and

pharmaceutical inputs produced in Mercosur, besides coordinating the

project of internationalization of the sector.


[email protected]

+55 61 3426-0202

www.apexbrasil.com.br

Apex-Brasil

The Brazilian Trade and Investment Promotion Agency (Apex-Brasil) works to promote Brazilian

products and services abroad, and to attract foreign investment to strategic sectors of the

Brazilian economy.

The Agency carries out several commercial promotion initiatives, such as commercial and

prospective missions, business rounds, support to the participation of Brazilian companies in

major business fairs, and visits of foreign buyers and opinion formers to assess the Brazilian

productive structure, among other business platforms aimed to strengthen the Brazil brand. The

Agency supports more than 11,000 companies from 80 different industries, which in turn export

to 200 markets.Apex-Brasil also acts to promote the competitiveness of Brazilian companies in

their internationalization process, especially in market intelligence, business training and image

promotion, as well as foreign direct investment (FDI) attraction.In this sense, the role of Apex-

Brasil is to promote the expansion of investments already made, and to make Brazil appear on

the “short list” of target countries and influence the investment decision by providing strategic

information, full support to the work of website location (arranging and accompanying the

visits of foreign companies to potential receptors States) and an aftercare work.In addition to its

headquarters in Brasilia, Apex-Brasil has nine business offices in important global markets, to assist

in the process of internationalization of Brazilian companies, prospectbusiness opportunities

and enhance national participation in major global markets, also serving as a reference for

the attraction of foreign investment. The business offices are located in Asia (Beijing, China),

the Middle East (Dubai, United Arab Emirates), North America (Miami and San Francisco, USA),

South America (Bogotá, Colombia), Central America and the Caribbean (Havana, Cuba), Europe

(Brussels, Belgium), Eurasia (Moscow, Russia) and Africa (Luanda, Angola).


Pantone 309 C

Pantone 309 U

C 100 M 0 Y 0 K 90

R 0 G 37 B 59

# 00243b

Suvinil

Azul Marinho

Oracal Vinil

Dark Blue 050

Suvinil

Azul Piscina

Oracal Vinil

Ice Blue 056

Pantone 298 C

Pantone 298 U

C 55 M 0 Y 0 K 0

R 144 G 202 B 241

# 90caf1

Suvinil

Azul Átomo

Oracal Vinil

Sky Blue 084

Pantone 7704

Pantone 7460 U

C 100 M 40Y 20 K 0

R 19 G 116 B 16v

# 1374a3

Versões Oficiais Com degradêPantone

Artes-finais logo Sindusfarma

Versões Oficiais Com degradêCMYK

Versão SecundáriaSem degradê - PositivaPantone

Versão SecundáriaSem degradê - PositivaCMYK

Partners

Abifina - Brazilian Fine chemicals industries,

biotechnology and Specialties Association

www.abifina.org.br

Alanac - National Pharmaceutical

Laboratories Association

www.alanac.org.br

Interfarma - National Pharmaceutical

Laboratories Association

www.interfarma.org.br

Pro Genéricos - Brazilian Generic Medicines Industry

Association

www.progenericos.org.br

Sindusfarma - São Paulo State’s Pharmaceutical

Industry Business Association

www.sindusfarma.org.br


Brazilian Pharmaceutical MarketThe Brazilian pharmaceutical market is one of the most important in the world. In terms of

size, it’s the 6th biggest one, and it’s supposed to become the 4th by 2016. Some of the

biggest pharmaceutical companies in the world are installed in the country, and it also counts

on a strong national industry. In the last decade, this industry tripled its sales, which are due

especially to the evolution of household income, meaning that now people are consuming

more medicines. Although branded medicines are still very relevant for the industry, the

generic medicines market is growing more and more each year, representing already one

quarter of the total national market. Despite the evolution of income, the purchasing power

is still relatively low, so this factor, combined to the generic’s popularity, makes this one grow

with bigger rates than branded medicines.

The Brazilian dynamic in the healthcare sector makes the country one of the most promising

and attractive in the world, despite the system’s complexity. One of the highlights is that

Brazil is the only country in the world that has a free public universal healthcare system, which

means taxes paid by people cover all kinds of treatment offered by the Brazilian Unified Health

System without charging the user. This system is also responsible for purchase and distribution

of medicines, especially the ones for continuous use, destined to the ones with low income.

At the same time, Brazil also has a strong private healthcare market, which represents almost

as much as the government spends to treat people.


Among the most popular consumed products, it’s possible to include the ones destined to

lowering cholesterol and hypertension control, besides OTCs and others related to lifestyle.

Another important point is that, although the disease’s profile in Brazil is reaching the ones

found in developed countries, like USA, there are still usual diseases from under development

countries, such as dengue, yellow fever and Chagas disease. Concerning the products

produced in Brazil, the national industry specialty is producing generic medicines for all sorts

of diseases, such as cardiovascular system diseases, anti-infective, digestive/metabolic, central

nervous system, anti-inflammatory, dermatological, respiratory, oncological, and many others.

Those products are sold not only in the local market, but also in several countries in the whole

world.

There is no doubt that Brazil is an emerging and promising market for the pharmaceutical

sector. It is dynamic is encouraging new projects to develop biotechnology products, with

also new politics from states and municipal governments to encourage new investments

so they could build new industrial centers. These new programs have been assuring the

improvement of infrastructure and more qualified workers.

The national agency that regulates everything in this market is ANVISA – Brazilian Health

Surveillance Agency – that is part of the National Health Surveillance System (SNVS, in

Portuguese). This system is responsible for assure the quality and the effectiveness of medicines

and healthcare products and it’s a government network connected to the Brazilian Unified

Health System. ANVISA coordinates and articulates the SNVS.

ANVISA is responsible for drug registration and licenses to pharmaceutical laboratories and to

other companies inside the pharmaceutical production flow. The agency is also responsible

for establishing regulations applicable to clinical trials and drug pricing, which is carried out

by the Chamber of Drug Market Regulation (CMED).

Together with states and municipalities, the agency inspects factories, monitors the quality of

drugs, exercises post-marketing surveillance, takes pharmacovigilance actions, and regulates

drug promotion and marketing. Moreover, ANVISA is in charge of analyzing patent requests

related to pharmaceutical processes and products, in partnership with the National Industrial

Property Institute (INPI).

Source:Sindusfarma (2015) PWC (2013)


Cristália Produtos Químicos Farmacêuticos

With 76 granted patents and 42 pending applications around the world, Cristalia ranks a

leading position in sales of anesthetics and allied products in Latin America. With 6 own

industrial units in Brazil and Argentina with GMP Certificate granted by Health Authorities,

Cristalia exports anti-Aids, psychiatric, pain management, oncology, biotechnology finished

dosages and APIs to more than 30 countries. Awarded by renowned institutions as an

Innovative Company in the pharmaceutical market, also has over 30 molecules synthesized

internally, including Sevoflurane (inhalatory anesthetic) and Lodenafil Carbonate (erectile

dysfunction treatment). Cristalia has about 4,000 employees, and among them hundreds of

scientists working to develop drugs that provide benefits to patients.

COMPANY ADDRESS:

Av. Paoletti, 363, Nova Itapira Itapira - SP - Brazil Zip Code: 13974-070

COMPANY DESCRIPTION:

CONTACT:

Carlos Manzo - Export ManagerEmail: [email protected] Number: + 55 (19) 3863-9500Website: www.cristalia.com.br


Eurofarma Laboratorios S.A.

Eurofarma is the 1st multinational pharmaceutical company from Brazil and it is currently

present with its own operations in 19 countries in Latin America.

Among the 3 largest pharmaceutical companies in Brazil, Eurofarma counts on over than

6.000 employees and 11 manufacturing plants, producing around 260 million units (boxes)

per year, with high quality, bioequivalence studies, at the right price.

Internationalization is one of the main strategic goals of the company. With a strong plan to

enlarge its portfolio in all countries around the world, Eurofarma provides dossiers for registration

and manufacture finished products with the brand and layout required by the clients.

Eurofarma has built more than 40 years of history providing access to health and quality of life,

sharing its value with employees and society.

COMPANY ADDRESS:

Av. Vereador Jose Diniz, 3.465,Campo BeloSao Paulo - SP - BrazilZip Code 04603-003


CONTACT:

Daniel Faria | Elaine Quintela | Priscilla MarcossiEmail: [email protected] Number:+ 55 (11) 5090-8538 – Daniel+ 55 (11) 5090-8488 – Elaine+ 55 (11) 5090-8793 – Priscilla Website: www.eurofarma.com.br


Centroflora CMS


Biolab Farmacêutica

Biolab is one of the 10 largest pharmaceutical companies in Brazil. Biolab counts on over

2,000 dynamic and entrepreneurial professionals who anticipate market needs and dedicate

continuously to evolution. Biolab is committed to the future and, therefore, we invest 10%

of our revenues in Research, Development and Innovation. The strategic partnerships

with companies, universities and research centers worldwide strengthen our international

representation.

Leader in the Brazilian market of prescription drugs in the field of Cardiology, Biolab has a

portfolio of over a 100 products and has significant activities in the areas of gynecology,

dermatology, gastroenterology, rheumatology, orthopedics, pediatrics, dermocosmetics,

among others.

COMPANY ADDRESS:

Rua Olimpíadas, 242 - 3º floorVila OlímpiaSão Paulo - SP - BrazilZip Code: 04551-000


CONTACT:

Email de contato:[email protected]:55-11-3573-6328Endereço: Rua Olimpíadas, 242 – 4º andarWebsite: www.biolabfarma.com.br


EMS Pharma

EMS is the 1st pharmaceutical industry in Brazil and the 2nd largest in Latin America. EMS is a

key player in most of therapeutic areas among OTC, generics, brand and hospital drugs with

a wide portfolio of more than 2.400 finished products including Solids, semi solids, orals and

syrups. EMS has been leading the pharmaceutical market for the last 9 consecutive years, EU-

GMP, exporting to over than 40 countries.

EMS owns the one of the biggest and most modern R&D department in Latin America, having

important launches every year and counts with 2 plants of high technology that provides a

capacity of 540 million packs/year.

COMPANY ADDRESS:

Adress: Rod. Jorn. Francisco A. Proença, KM 08 Bairro Assay – Hortolandia – SPBrasil


CONTACT:

Email: [email protected]@ems.com.brPhone number: +55 19 3795-9041 +55 19 3795-9057Website: www.ems.com.br


Kin Master Produtos Químicos Ltda.

Kin Master was established in 1978 and is GMP Certified. Kin Master is an experienced company committed to achieving excellent results in the production of Active Pharmaceutical Ingredients from bovine and porcine origins.

Among our products are :

COMPANY ADDRESS:

Rua Manoel Portela, 780 - Passo FundoRio Grande do Sul - BrasilCEP 99010-115


CONTACT:

Andre Bertolucci General Manager + 55 54 3313-2700 , + 55 54 8114 2535 Email: [email protected] Website: www.kinmaster.com.br

Bile Total Bile Salts Bovine Bile Extract

Enzymes Pancreatin 3NF to 10NF Pepsin

Liver Dessicated Liver NF XI Fraction Liver G Cohn Liver Extract for Injectable Paste Antitoxic Liver Fraction

Hydrosoluble Extracts Collagen Liver Placenta Thyroid Meat Thymomodulin Supra Renal Others

Glycosaminoglycans Heparin Sodium Injectable Heparin Sodium Topical Heparinoids Mucopolysacharide Polysulfuric Acid Mesoglycan Chondroitin Sulfate A Oral Chondroitin Sulfate A Injectable


Libbs

It´s how we treat life

AF_anuncio_CPHI_21x29,7cm_english.indd 1 30/09/15 14:22


Nortec Química

NORTEC QUIMICA is an Independent Manufacturer of Active Pharmaceutical Ingredients

(Outsourcing). Supplying more than 200 customers in Brazil and abroad, exporting to more

than 20 countries, NORTEC QUIMICA is the major API manufacturer in Latin America. NORTEC

QUIMICA currently manufacures more than 50 APIs, including antiretrovirals, local anesthetics,

cardiovasculars, benzodiazepines, CNS drugs, among others. Located just 50 km from Rio de

Janeiro, NORTEC QUIMICA enjoys the benefit of one of the most important Brazilian Logistic

Hubs.

NORTEC QUIMICA is a listed company and is proud of having the Brazilian Development Bank

- BNDES - among its shareholders.

COMPANY ADDRESS:

Rua Dezessete, 200Distrito Industrial Duque de CaxiasXerem - Rio de Janeiro – BrazilZip Code: 25250-612


CONTACT:

João JuniorPlanning, Commercial and Logistics DirectorEmail: [email protected] Phone Number: + 55 (21) 3651-7300Website: www.nortecquimica.com.br


Extrasul

Established in 1982, Extrasul is specialized in and one of the world largest suppliers of heparin

and chondroitin sulphate to the pharmaceutical, pharmochemical and veterinary industries.

The company has had GMP certification since 2008 and it is certified and yearly inspected by

Anvisa – Brazilian National Sanitary Agency. Extrasul has high qualified staff and up-to-date-

technology, which guarantees reliability, traceability and scale of their products.

Main products: Porcine Sodium Heparin, Bovine Sodium Heparin and Bovine Chondroitin

Sulfate.

COMPANY ADDRESS:

Estrada HT 005 Km 01, Zona RuralJaguapitã - Paraná - BrazilZip Code: 86610-000


CONTACT:

Fabian Magalhães E-mail: [email protected] Number: +55 11 3097-5544Website: www.extrasul.com.br


Globe Química

Globe Química S.A. is one of the three major Brazilian API manufacturers with GMP - Good

Manufacturing Practices certified by ANVISA.

Located in the city of Cosmopolis at Campinas Metropolitan Area, its website has 110 Acres

with five Chemical Synthesis Plants and dedicated areas for synthesis of active ingredients for

cancer drugs, drying, milling, micronization and packaging of products for the pharmaceutical

industry.

Globe Química S.A. produces Antiretroviral, C.N.S., Oncologic, Cardiovascular APIs and many

others.

COMPANY ADDRESS:

Rodovia SP-332, Km 136Cosmópolis, SP - BrazilZip Code: 13150-000


CONTACT:

Robert Caggiano | Sales Director Email: [email protected] Phone Number: +55 (19) 3872-8700

Website: www.globequimica.com.br


IQT – Taubaté Chemical Industry

IQT Chemical’s custom manufacturing and fine chemical business is focused on synthesis of

organic molecules for pharmaceutical, agrochemical and industrial / consumer markets.

At cGMP API manufacturing locations with Regulatory approvals, commercially produces APIs

of quality which serves as a benchmark.

COMPANY ADDRESS:

Irmãos Albernaz St, 300Taubaté – São Paulo - Brazil


CONTACT:

Phone: + 55 12 21259600Email: [email protected]: www.iqt.com.br


União Química Farmacêutica Nacional S/A

Uniao Quimica is one of the largest and strongest companies in the Brazilian pharmaceutical

industry with more than 70 years of experience. With 100% national capital, it’s divided into

two business units: Human health and Animal Health. União Química’s most important

focus is quality, allied to competitive price, thus transforming challenges into solutions and

overcoming the expectations of Pharmaceutical Market, its customers and the consumers.

União Quimica has recently acquired Novartis, Taboão da Serra site, based in Brazil, and

therefore will be responsible for their Brazil and Latino America portfolio production.

União Quimica’s current focus is to offer to new companies the outsourcing of their production.

COMPANY ADDRESS:

Av. Magalhaes de Castro ,4 800 -16o floor Complex 161 - 162Cidade Jardim - São Paulo - BrazilZip Code: 05676-120


CONTACT:

Ursula Cristina FavaleDirector of ImportEmail: [email protected] Number: + 55 (11) 5586-2010+ 55 (11) 5586-2022Website: www.uniaoquimica.com.br


Biolotus Biotech is a pharmaceutical company specializing in research, development, registration, manufacture, promotion, distribution and worldwide commercialization of pharmaceutical products from biotechnology origin. Biolotus started operating in January 2001 concentrating the activities in Latin America and Caribbean and since 2005 extending its presence to the Middle East, Africa and Europe.In 2007 Biolotus started focusing on INDAs. Currently, development programs comprehend two cancer projects both coming to phase II, a hemorrhagic product and a product for aspergillosis. Biolotus is also aiming at local manufacturing of monoclonal antibodies and diagnostics.While maintaining its predominant international presence, Biolotus is increasingly focusing in the Brazilian market, aiming at innovation. We intend to provide a long-lasting service through our know-how in pharmaceutical development, registration and market penetration in all continents contributing to a

COMPANY ADDRESS:Av Evandro Lins e Silva 840, SL 319, Barra da Tijuca, Rio de Janeiro - RJ - Brazil, Zip Code: 22631-470

CONTACT: Nicole Chaves | PharmD Email: [email protected] company: [email protected] Number: + 55 (21) 2480-2405, + 55 (21) 98206-9998Website: www.biolotus.com

better and healthier world.Biolotus Biotech has currently research cooperation projects with several entities to develop new products and welcomes new partnerships.Our mission is To Serve!Key words: biotech, cancer, monoclonal, antibodies, biotechnology, proteins, zeolites, pharmaceutical, aspergillosis, diagnostics.

biolotus

Founded in 1988, Atitude is an internet company specialized in professional live streaming, and a preferred partner for the Brazilian life science segment.

Mission: Development of technologies that make business communication more efficient and humanized, shortening distances between professionals and the marketplace.

Online technologies:

WebMeeting STUDIO: Supports transmissions to large audiences allowing the organization of events for training, product launch, continuous medical education, strategy alignment, etc.

WebMeeting CORP: Dedicated infrastructure built in house in companies’ offices. Supports a variety of internal events, increasing communication among companies’ employees and franchises.

WebMeeting DIRECT: Supports events for up to 20 connections with two ways audio and video

COMPANY ADDRESS:Rua Bragança Paulista, 145São Paulo – SP – BrazilZip Code: 04727-000

CONTACT: Hamilton Conde | General [email protected] Costa | Business development [email protected]

Helder Conde | Technology [email protected]

Phone Number: +55 11 5643-6464Site: www.atitude.com.br

communication and content sharing between all participants.

WebMeeting VISIT: Supports one to one interactions with content share, compliance parameters and monitoring. Suitable for medical and business virtual detailing.

atitude

10 YEARS

Centro Avançado de Estudos e Pesquisas

CAEPBIOEQUIVALENCEAND BIOAVAILABILITYSTUDIES

CLINICAL RESEARCH

STATISTICS

REGULATORY AFFAIRS

PHARMACEUTICALEQUIVALENCE STUDY(in vitro Test)

ANALYTICAL CENTER

FOOD

VETERINARY DRUG RESIDUES

Centro Avançado de Estudos e Pesquisas LtdaRua José Geraldo Cerebino Christófaro, n° 245Fazenda Santa Cândida CEP 13087-567 Campinas/SPTel: +55 (19) 3756.6893

www.caepcampinas.com.br

Contact: Ana Cláudia de Paiva - Gerente ComercialEmail: [email protected] Number: + 55 (19) 3756-6878

CAEP is an independent Clinical Research Center certified by ANVISA, specifically designed for performing Bioequivalence Studies, Phase I-IV Clinical Trials and Analytical Laboratory Services.


Biomm is a company resulting from the spin-off of Biobrás, a pioneering player in pharmaceutical biotechnology in Brazil. Its activities include commercialization, promotion, manufacturing and development of biosimilars such as insulins and monoclonal antibodies in Brazil.

It is the only publicly held Brazilian biotech with stocks traded at Brazilian s Stock Exchange BOVESPA (BIOM3).

Biomm holds several patents granted in selected countries, like Brazil, France, Germany, India, United Kingdom and USA.

The company is building a state-of-the-art biopharmaceutical plant in Minas Gerais to manufacture insulin products and other biosimilars using a technological platform developed in Brazil and patented in the USA, Europe and Asian countries. The company’s production processes have been reviewed and approved by international regulatory agencies.

COMPANY ADDRESS:Praça Carlos Chagas, 49, 8th floorBelo Horizo nte, MG, Brazil Zip Code: 30170-020

CONTACT: Contact: Ciro Massari - Commercial DirectorEmail: [email protected] Number: +55 31 3299-1000Website: www.biomm.com

Biomm´s interest is to discuss long-lasting mutual beneficial partnerships in tech transfer, co-development and in licensing of biopharmaceuticals from any stage of advance.

With a track record of more than 30 years, a high quality innovative team and a capital structure that enables Biomm to advance in different projects, Biomm is your ideal partner for biopharmaceuticals in Brazil.

biomm

CAEP - Centro Avançado de Estudos e Pesquisas

10 YEARS

Centro Avançado de Estudos e Pesquisas

CAEPBIOEQUIVALENCEAND BIOAVAILABILITYSTUDIES

CLINICAL RESEARCH

STATISTICS

REGULATORY AFFAIRS

PHARMACEUTICALEQUIVALENCE STUDY(in vitro Test)

ANALYTICAL CENTER

FOOD

VETERINARY DRUG RESIDUES

Centro Avançado de Estudos e Pesquisas LtdaRua José Geraldo Cerebino Christófaro, n° 245Fazenda Santa Cândida CEP 13087-567 Campinas/SPTel: +55 (19) 3756.6893

www.caepcampinas.com.br

Contact: Ana Cláudia de Paiva - Gerente ComercialEmail: [email protected] Number: + 55 (19) 3756-6878

CAEP is an independent Clinical Research Center certified by ANVISA, specifically designed for performing Bioequivalence Studies, Phase I-IV Clinical Trials and Analytical Laboratory Services.


“In every day learning process Geolab produces much more than drugs. We provide smiles. We are a young company that respects the teachings of yesterday to meet customer expectations today.

Geolab Pharmaceutical Company, a company established in DAIA in Anápolis-GO, the largest pharmaceutical center in Latin America. In the moment that multinationals invest in the country, Geolab reinforces the commitment to entrepreneurship with 100% national capital and employing around 1,200 employees.

In 2014 and 2015 Geolab underwent an expansion in its industrial park that today reaches 40,000 m² area. Among the new areas are the research and development institute, stockroom and storage of finished products.”

COMPANY ADDRESS:Via Principal 1B, Quadra 08B, Modulos 1 a 8, DAIA, Anapolis, Goias, Anapolis. CEP: 75.132-085

CONTACT: Contact: Rafaella Chimiti – Develop ManagerE-mail: [email protected] Number: 55 62 4015 4044Website: www.geolab.com.br

geolab

ECOTAG COMERCIAL LTDA

AddressRua Maria Monteiro, 830 - cj.61Edificio Office Park - Cambui13025-151 Campinas, SP, Brazil

Contact:Umberto Nespoli

Email: [email protected]

Phone Number:+ 55 (19) 3236 4444 + 55 (19) 9 8121 0809

Site:www.ecotag.com.br

Company descripon:

THE RIGHT PARTNER IN BRAZIL

Agency is our business. We work in the pharmaceucal segment since the year 2002, promong our premium partner companies to a powerful range of buyers. In this process, we create profitable and successful partnership.

DO YOU WANT TO SELL IN THE BRAZILIAN MARKET?

We offer to our premium partners companies: Individual approach, Markeng informaon, Process and Payment follow-up, leading to Successful and Profitable Long-Term Relaonship.

We deal with Acve Pharmaceucal Ingredients (APIs), Veterinary products, Food Ingredients, Extracts, Finished dosage.

ecotag


An innovative Brazilian biotechnology company formed by a joint venture between Biolab and Eurofarma. As a result of a stimulus by the Brazilian government, Orygen’s initial focus is on the establishment of a state of the art production plant for the manufacture of biosimilar monoclonal antibodies. In parallel, we are currently prospecting other business, such as in-licensing, partnering and co-development opportunities, while we initiate the development of our own proprietary biotherapeutic products.

COMPANY ADDRESS:Rua Ministro Jesuíno Cardoso, 633 conjunto 102Vila Nova Conceição, São Paulo-SP

CONTACT: Priscila ScheinbergEmail: [email protected] Number: (11) 3044-3995 Website: www.orygen.com.br

orygen

T&B Pharma

companyOur Company is based on a partnership with GMP specialists with solid knowledge of the pharmaceutical, API, veterinary, cosmetic, and medical device.

The constant pursue of the regulatory status update leads to trainings of professionals responsible for these areas. Our expertise can contribute to your company, enabling it to achieve better results. Currently, besides working to attend our client’s demands, we offer a diversity of consultants and company partners, which broadens our services scope and enables us to offer you quick and robust answers.

Our scope is directly related to Quality Systems, GMP, Validations, Audits, Supplier Qualification, Trainings, etc., offering to you, fast, safety and effective solutions.Helping you do better in GMP concepts

Visit our Blog: http://tbpharma.com.br/blog/ | www. tbpharma.com.br | [email protected]

(11) 4962-3171 • (11) 98228-5883 | twitter.com/tbpharmaconsult | facebook.com/tbpharma.consultoria

“our mission is helping you do better in Gmp concepts”

QUaLITy• ImplementationofQualityManagementSystem.• Validations(ManufacturingProcess,Cleaning,WaterSystem,etc.,).• PeriodicProductQualityReview.• SiteMasterFile–ElaborationandReview.• TechnicalSupport-GMP.

manUFacTURInG• ImplementationofQualityManagement.• OperatorsQualificationandCertificationProgram.• Layoutreviewformaterialsandpersonnelflows.

QUaLITy aUDITS• MockinspectionsforANVISA,FDA,EMAandWHOrequirements.• ActionPlanandfollow-upactions.• InternationalAudits–SupplierQualification(APIandFinished

Products).

TRaInInG• Trainingprogramandqualificationtoreachthespecific

client needs.• TrainingsforQualityAssurance,QualityControl(GLP)andcGMP.


We are a Brazilian company with over 30 years of experience, initially focused on providing high quality excipients, as super disintegrants, binders, fillers, suspending and viscosity increasing agents, for pharmaceutical, food and other industries. Being recognized for the high level of quality and technical assistance to the customers, our excipients are currently sold in over 100 countries in all continents. We also have a pharmaceutical manufacturing facility, with over 15 years of experience producing finished solid dosage forms.Having products in Antiretroviral and Osteoporosis therapeutic classes, our pharmaceutical plant is designed to meet the most demanding qualification criteria from regulatory bodies. We are committed to exceeding the expectations of our customers worldwide.

COMPANY ADDRESS:Rua Joaquim Faustino de Camargo, 201 Taboão da Serra – São Paulo – Brazil

CONTACT: Email: [email protected] Phone Number: +55 (11) 4138-8200Website: www.blanver.com

blanver

Formil Qu’mica Ltda is a Brazilian company founded in 1973, whose factory is located in the city of Barueri State of Sao Paulo. We produce, by chemical synthesis or extraction, and sell IFA’s (Active Pharmaceutical Ingredients) in domestic and foreign market for human pharmaceutical, veterinary and cosmetic industries. Our expertise is in constant search of innovations developed by our R & D department autonomously, with collaboration from universities and research centers and partnerships with its customers. Industrially, we manufacture products under the strictest GMP (Good Manufacturing and Control Practices), ensuring the quality and reliability of products, processes and services.Formil research and produces thinking of the customer. Our R & D, Commercial, and Assurance and Quality Control departments, focused on the needs of each client, work directly, customizing the product, whenever necessary, and suit it to your needs. Contact us to confirm the technical and commercial viability in providing this service.

COMPANY ADDRESS:Estrada Velha de Itú, 800 - Jardim BelvalBarueri - SP - CEP: 06422-144Brasil

CONTACT: Pedro IglesiasEmail: [email protected] Number: +55 11 4789-8701Website: www.formil.com.br

FORMIL QUÍMICA


Coordinated by

CPHI 2015 | BRASIL

Documents

Transcript of CPHI 2015 | BRASIL